India is rapidly establishing itself as a global hub for neutraceutical active pharmaceutical ingredient manufacturing, driven by a combination of factors including competitive rates, a skilled workforce, and supportive government initiatives. Numerous businesses are now focusing on the synthesis and distribution of these crucial compounds used in